Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy

Nature Biotechnology 2026

View at publisher
Authors: Shuai Xu, Tianjiao Zhang, Y N Song, Mengxin Wang, Mei Wu, Mofan Li, Haonan Wang, Mingquan Xie, Qingfeng Chen, Xiaotu Ma, Xiaolong Liang
DOI: 10.1038/s41587-026-03054-y
Cited by: 7
References: 64

Fields of Study & Subjects

Cancer Research and Treatments Immune cells in cancer Neuroblastoma Research and Treatments

Publication details

Journal / source
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
Publication date
18 March 2026
Language
EN